Monoclonal gammopathy with cutaneous significance treated successfully with rituximab

J Dtsch Dermatol Ges. 2022 May;20(5):697-700. doi: 10.1111/ddg.14751. Epub 2022 May 8.

Authors

Eleni Koutra¹, Elke Lusmöller¹, Rudolf Stadler¹, Ralf Gutzmer¹

Affiliation

¹ University Clinic for Dermatology, Venereology, Allergology and Phlebology, Johannes Wesling Clinic, Minden, Germany.

PMID: 35527337
DOI: 10.1111/ddg.14751

No abstract available

Publication types

Letter

MeSH terms

Administration, Cutaneous
Humans
Monoclonal Gammopathy of Undetermined Significance* / drug therapy
Paraproteinemias* / drug therapy
Rituximab / therapeutic use
Skin

Substances

Rituximab